SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Persistent Immune Activation and Inflammation During Antiretroviral Therapy
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
Session Overview - Persistent Immune Activation and Inflammation During Antiretroviral Therapy
Frank Maldarelli
National Cancer Institute, Frederick, MD, USA
Low-Level HIV Viremia Affects T-Cell Activation and Senescence in InSTI Era (ABSTRACT
348)
Violeta Lara Aguilar
Institute of Health Carlos III, Madrid, Spain
Ultra-Low Level HIV p24 Production as a Driver of Immune Activation in Individuals Treated with ART (ABSTRACT
349)
Enrico Richter
Bonn University Hospital, Bonn, Germany
CARD8 Activation in Myeloid Cells as a Driver of Inflammation in HIV Infection (ABSTRACT
350)
Marilia R. Pinzone
Washington University in St Louis, St Louis, MO, USA
Increased Immune Activation Following Acute Sleep Deprivation in People With HIV on ART (ABSTRACT
351)
Bernard J. C. Macatangay
University of Pittsburgh School of Medicine
Immunosuppressive Effects of LLDT-8 in ART-Treated SIV-Infected Rhesus Macaques (ABSTRACT
352)
Xiaosheng Liu
Tsinghua University, Beijing, China
Discussion with Audience Questions and Answers
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
